FDA revokes EAUs for non-NIOSH and decontaminated respirators

Effective this month, the U.S. Food and Drug Administration (FDA) revoked emergency use authorizations (EUAs) for non-NIOSH-approved disposable respirators and for decontamination and bioburden reduction systems. Based on the increased domestic supply of respirators approved by the Centers for Disease Control and Prevention's (CDC) National Institute for Occupational Safety and Health (NIOSH), and consistent with the CDC's updated recommendations to protect health care workers, the FDA stated health care facilities should no longer use crisis capacity strategies. These were previously recommended to address respirator shortages earlier in the COVID-19 outbreak. (FDA update, 6/30/21)